Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
10/17/2007 | CN100342847C Stomach nourishing dispersible tablet with aucklandia root and amomum fruit and its preparation method |
10/17/2007 | CN100342846C Compression molded product and production method therefor |
10/17/2007 | CN100342845C Moisture-proof coating method for Chinese medicine granule |
10/16/2007 | US7282578 Having at least one intron sequence; constructs and host cells; expression product and antibodies obtainable by immunization of an animal therewith, as well as the use of antibodies in screening methods for the identification of tumors |
10/16/2007 | US7282489 Delivering plasmid vector encoding HERG (A561V) (human ether-a-go-go related gene) protein to cells afflicted with re-entrant atrial flutter mediated cardiac arrhythmia |
10/16/2007 | US7282486 A dosage form of pure crystalline azithromycin monohydrate hemi-ethanol solvate and a carrier or diluent; nuclear magnetic resonance spectrum analysis; bactericides; antiprotozoa agents; infections of humans, mammals, birds and fish; drug resistance |
10/16/2007 | US7282358 Monochromatic fluid treatment systems |
10/16/2007 | US7282221 Dosage forms of antiviral and a carrier; an immediate release dosage form and delayed release dosages, each initiates release at different times; product contains the total dosage of the antiviral for a twenty-four hour period |
10/16/2007 | US7282220 Administering heparin which is encapsulated within a gelatin carrier |
10/16/2007 | US7282219 Medicine of high molecular weight such as insulin and a cationic polymer such as aminoalkyl methacrylate copolymer, the preparation further comprising at least one kind of basic amino acid or salt |
10/16/2007 | US7282218 Pharmaceutical composition; hydrophobic monomer, a basic monomer, a hydrophilic monomer and an amorphous form of a bitter drug within the polymer matrix; inhibits the crystallization of the drug during formulation and reconstitution |
10/16/2007 | US7282217 Rapidly disintegrable tablets |
10/16/2007 | US7282216 Prepared by blending hydrophobic biocompatible, biodegradable polymers or copolymers, such as poly(lactide-co-glycolide), and a biocompatible, amphipathic copolymer having a water absorption ratio of 2 or less; sustained release drug delivery |
10/16/2007 | US7282215 Supports for photosensitizer formulations |
10/16/2007 | US7282214 Biomedical devices with antimicrobial coatings |
10/16/2007 | US7282195 comprises non-oil natural/artificial flavoring agent, ultraviolet light absorber, curing system, and filler; for repairing/protecting teeth |
10/16/2007 | US7282194 Nanoparticles for protein drug delivery |
10/16/2007 | US7282045 Ingestible device |
10/16/2007 | US7281641 Stackable low depth tray |
10/16/2007 | CA2538996C External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities |
10/16/2007 | CA2336654C Plaster which contains steroids, and a method for the production and use thereof |
10/16/2007 | CA2248087C Improved vision through photodynamic therapy of the eye |
10/16/2007 | CA2237699C Novel protein complexes |
10/16/2007 | CA2214026C Pharmaceutical compositions comprising monoamine oxidase b inhibitors |
10/16/2007 | CA2159609C Factor xiii for treatment of skin wounds |
10/16/2007 | CA2114250C Use of relaxin in cardiovascular therapy and in the treatment of neurodegenerative diseases |
10/11/2007 | WO2007115305A2 Oral dosage forms including an antiplatelet agent and an acid inhibitor |
10/11/2007 | WO2007115147A2 Thermometer |
10/11/2007 | WO2007115146A2 Protection against charging damage in hybrid orientation transistors |
10/11/2007 | WO2007115143A2 Dead spindle pto with compliant grounding mechanism |
10/11/2007 | WO2007115135A2 Aircraft passenger seat |
10/11/2007 | WO2007115043A2 Valves having corrosion resistant ceramic coating |
10/11/2007 | WO2007114977A2 Lithium-metal-oxide composite electrodes |
10/11/2007 | WO2007114921A2 Pharmaceutical formulations: salts of 8-[{1-(3,5-bis (trifluoromethy1)pheny1)-e thoxy}-methy1]-8-pheny1-1,7-diaza-spiro[4.5] decan-2-one and treatment methods using the same |
10/11/2007 | WO2007114898A1 Film-coated solid dosage forms |
10/11/2007 | WO2007114881A1 Technology for preparation of macromolecular microspheres |
10/11/2007 | WO2007114797A1 Porous tablets for subsequent filling with active pharmaceutical ingredient |
10/11/2007 | WO2007114380A1 Agent for external application to the skin |
10/11/2007 | WO2007114376A1 Solid pharmaceutical preparation |
10/11/2007 | WO2007114315A1 Therapeutic agent for corneal/conjunctival disorder |
10/11/2007 | WO2007114301A1 Stabilizer for composition containing water-soluble polymer thickener |
10/11/2007 | WO2007114262A1 Casein nanoparticle |
10/11/2007 | WO2007114128A1 Method for production of capsinoid-containing beverage/food |
10/11/2007 | WO2007114013A1 Composition containing lignan compound |
10/11/2007 | WO2007113857A2 Modified release clopidogrel formulation |
10/11/2007 | WO2007113762A2 Bulking of soft tissue |
10/11/2007 | WO2007113665A2 Polymerized solid lipid nanoparticles for oral or mucosal delivery of therapeutic proteins and peptides |
10/11/2007 | WO2007113536A1 A tablet of paracetamol containing an encapsulated flavorant |
10/11/2007 | WO2007113454A1 Particulate compositions comprising alginate and/or alginic acid |
10/11/2007 | WO2007113371A1 Pharmaceutical composition and preparation method thereof |
10/11/2007 | WO2007113207A2 Coated formulations |
10/11/2007 | WO2007113187A1 Oral pharmaceutical coated composition for pulsatile release |
10/11/2007 | WO2007113008A2 Opaque container comprising food or pharmaceutical products or herbal(s) |
10/11/2007 | WO2007112986A1 Compositions, methods, and kits using adenosine and inosine in combination for diagnosis and treatment |
10/11/2007 | WO2007112967A1 Process for the preparation of water-in-oil and oil-in-water nanoemulsions |
10/11/2007 | WO2007112750A2 Tablets and capsules comprising immunogens for oral administration |
10/11/2007 | WO2007112747A1 Immunogen combinations |
10/11/2007 | WO2007112619A1 Oseltamivir phosphate granule and preparation mehtod thereof |
10/11/2007 | WO2007112581A1 Controlled release delivery device comprising an organosol coat |
10/11/2007 | WO2007112579A1 Drug delivery composition |
10/11/2007 | WO2007112574A1 Extended release composition of venlafaxine |
10/11/2007 | WO2007112567A1 Synthetic archaeal glycolipid adjuvants |
10/11/2007 | WO2007098128A3 Phenylephrine-containing liquid formulations |
10/11/2007 | WO2007078271A3 Lansoprazole orally disintegrating tablets |
10/11/2007 | WO2007073894A3 Oral preparation with controlled release |
10/11/2007 | WO2007072380A3 Method of making dried particles |
10/11/2007 | WO2007070632A3 Abuse resistant transmucosal drug delivery device |
10/11/2007 | WO2007057714A3 Pharmaceutical compositions comprising methotrexate |
10/11/2007 | WO2007053810A9 Liposomally encapsulated reduced glutathione, including with other pharmacologic preparation, capable of administration as an oral, topical, intraoral or transmucosal, preparation, for reversal and prevention of oxidation of cholesterol and of low density lipoprotein |
10/11/2007 | WO2007047994A3 Dental and endodontic filling materials and methods |
10/11/2007 | WO2007047948A3 Intranasal administration of rapid acting insulin |
10/11/2007 | WO2007041479A3 Pharmaceutical compositions |
10/11/2007 | WO2007039122A3 Solid orally administerable pharmaceutical dosage forms with rapid active principle release |
10/11/2007 | WO2007038802A3 Methods for preparing core-shell composites having cross-linked shells and core-shell composites resulting therefrom |
10/11/2007 | WO2007035336A3 Effervescent rehydrating beverage tablet/granules |
10/11/2007 | WO2007024826A3 Method of storing nanoparticle formulations |
10/11/2007 | WO2007022152A3 Lipid nano particulates containing antigens as cancer vaccines |
10/11/2007 | WO2007016679A3 Combination immediate release controlled release levodopa and carbidopa dosage forms |
10/11/2007 | WO2007014328A3 Compositions and methods for emulsifying a perfluorocarbon with an oxygen-carrying surfactant |
10/11/2007 | WO2007010442A3 Method and system for in vivo drug delivery |
10/11/2007 | WO2006112958A8 Methods and compositions for modified release of nutritional supplements |
10/11/2007 | WO2006087177B1 Solid peroral contraceptive drug |
10/11/2007 | WO2006084087A3 Compositions and methods for nutrition supplementation |
10/11/2007 | US20070239139 Instructional medical treatment system |
10/11/2007 | US20070238787 Pharmaceutical Methods, Dosing Regimes And Dosage Forms For The Treatment Of Alzheimer's Disease |
10/11/2007 | US20070238786 Pharmaceutical Methods, Dosing Regimes And Dosage Forms For The Treatment Of Alzheimer's Disease |
10/11/2007 | US20070238776 Novel Pyrroles Having Hypolipidemic Hypocholesteremic Activities, Process for Their Preparation and Pharmaceutical Compositions Containing Them and Their Use in Medicine |
10/11/2007 | US20070238759 Novel Polymorph V of Torasemide |
10/11/2007 | US20070238708 Acute Inflammatory Condition Treatment |
10/11/2007 | US20070238693 Genetic modification of the lung as a portal for gene delivery |
10/11/2007 | US20070238686 Inhibition of Chronic Myelogenous Leukemic Cell Growth By Liposomal-Antisense Oligodeoxy-Nucleotides Targeting To Grb2 or Crk1 |
10/11/2007 | US20070237871 Method for Producing Orally Administrable Edible Agent of Aggregated Substance-Containing Laminate Film Form and Orally Administrable Edible Agent of Aggregated Substance-Containing Laminate Film Form |
10/11/2007 | US20070237856 Impact of calcium phosphate complex on dental caries |
10/11/2007 | US20070237835 Peritoneal Dialysis Solution |
10/11/2007 | US20070237833 Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level |
10/11/2007 | US20070237832 Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level |
10/11/2007 | US20070237831 Nanoparticles for monoclonal antibody delivery |
10/11/2007 | US20070237830 for embolic treatment, treating uterine fibroids, and cancerous tumors; arteriovenous malformation |
10/11/2007 | US20070237829 Melanin nanoshells for protection against radiation and electronic pulses |
10/11/2007 | US20070237828 Ziprasidone Dosage Form |